059210 — Metabiomed Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩117bn
Enterprise Value
KR₩141bn
Revenue
KR₩83bn

Annual balance sheet for Metabiomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,097	21,044	15,916	19,141	16,810
Net Total Accounts Receivable
Net Total Receivables	15,861	12,181	13,047	14,504	14,534
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41,332	52,123	48,203	50,976	49,924
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	45,591	42,726	39,278	52,123	59,086
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	103,292	107,856	103,128	121,072	130,124
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39,343	47,410	38,161	44,817	44,471
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	50,024	59,878	44,805	60,481	60,077
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	53,267	47,978	58,323	60,591	70,048
Total Liabilities & Shareholders' Equity	103,292	107,856	103,128	121,072	130,124
Total Common Shares Outstanding